NEW YORK (TheStreet) -- Several small-cap stocks were poised to move on above-average volume during Wednesday's session
Novavax (NVAX) rose by 7 cents, or 1.8%, to $3.92 in the premarket session after the company said it has entered into a strategic collaboration with Xcellerex to develop a large-scale manufacturing process for its 2009 H1N1 influenza VLP vaccine. The three-month average daily volume for Novavax is 8.1 million, according to Yahoo! Finance. Cascade Financial (CASB) surged by 55 cents, or 35.7%, to $2.09 in the premarket session after the company late Tuesday said it had third-quarter earnings of $1 million, or 9 cents a share, After adjustments for the preferred stock dividend and accretion of the issuance discount on the U.S. Treasury preferred stock. Analysts had expected a loss of 53 cents a share, according to Thomson Reuters. The three-month average daily volume for Cascade Financial is 34,000, according to Yahoo! Finance. CombinatoRx (CRXX) jumped by 17 cents, or 12.8%, to $1.50 in the premarket session after the company said data from a 12-month phase II trial demonstrated that Synavive-treated subjects with knee osteoarthritis maintained efficacy levels. "Synavive appears to be well-tolerated and efficacious in reducing the signs and symptoms of knee OA over a 3 to 12-month period," said Robert Forrester, interim president and CEO of CombinatoRx. The three-month average daily volume for CombinatoRx is 715,000, according to Yahoo! Finance. Antigenics (AGEN) plummeted by 89 cents, or 42.6%, to $1.20 in the premarket session after the company said it was told by the Committee for Medicinal Products for Human Use of the European Medicines Agency to anticipate a negative opinion on the marketing authorization application for Oncophage in early-stage, localized renal cell carcinoma. The three-month average daily volume for Antigenics is 2.8 million, according to Yahoo! Finance. -- Written by Robert Holmes in New York. Check out all of Wednesday's high-volume, under-$5 stocks at the Dollar Store Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,883.95 | 1,349.96 | 2,915.86 | 19.75 |
Oil *
117.78
|
|
UP
5.75 |
UP
2.91 |
UP
11.78 |
UP
0.09 |
10 Yr
1.98%
SPDR Gold
168.50
|
|
+0.04%
|
+0.22%
|
+0.41%
|
+0.46%
|
Data delayed 20 minutes |

Connect with TheStreet